BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 26376710)

  • 21. 1.5-T MR relaxometry in quantifying splenic and pancreatic iron: retrospective comparison of a commercial 3D-Dixon sequence and an established 2D multi-gradient echo sequence.
    Plaikner M; Lanser L; Kremser C; Weiss G; Henninger B
    Eur Radiol; 2023 Jul; 33(7):4973-4980. PubMed ID: 36800012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic iron stores assessed by magnetic resonance imaging (MRI) in beta thalassemic patients.
    de Assis RA; Ribeiro AA; Kay FU; Rosemberg LA; Nomura CH; Loggetto SR; Araujo AS; Fabron Junior A; de Almeida Veríssimo MP; Baldanzi GR; Espósito BP; Baroni RH; Wood JC; Hamerschlak N
    Eur J Radiol; 2012 Jul; 81(7):1465-70. PubMed ID: 21501938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of pancreatic R2* for iron overload assessment in the presence of fat: a comparison of different approaches.
    Santarelli MF; Meloni A; De Marchi D; Pistoia L; Quarta A; Spasiano A; Landini L; Pepe A; Positano V
    MAGMA; 2018 Dec; 31(6):757-769. PubMed ID: 30043125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Segmental quantification of hepatic lipid content based on volumetric MRI data in patients with suspected iron overload.
    Wunderlich AP; Cario H; Kannengießer S; Grunau V; Götz M; Hüttner F; Backhus J; Beer M; Schmidt SA
    Rofo; 2024 May; 196(5):463-470. PubMed ID: 38081191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of fatty pancreas by proton density fat fraction using 3-T magnetic resonance imaging and its association with pancreatic cancer.
    Fukui H; Hori M; Fukuda Y; Onishi H; Nakamoto A; Ota T; Ogawa K; Ninomiya K; Tatsumi M; Osuga K; Yamada D; Eguchi H; Miyoshi E; Tomiyama N
    Eur J Radiol; 2019 Sep; 118():25-31. PubMed ID: 31439250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limits of Fat Quantification in the Presence of Iron Overload.
    Colgan TJ; Zhao R; Roberts NT; Hernando D; Reeder SB
    J Magn Reson Imaging; 2021 Oct; 54(4):1166-1174. PubMed ID: 33783066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of Pancreatic Iron Overload Measured by T2*-Weighted Magnetic Resonance Imaging in Diabetic Patients with β-Thalassemia Major.
    Kosaryan M; Rahimi M; Darvishi-Khezri H; Gholizadeh N; Akbarzadeh R; Aliasgharian A
    Hemoglobin; 2017 May; 41(3):151-156. PubMed ID: 28762844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interexamination repeatability and spatial heterogeneity of liver iron and fat quantification using MRI-based multistep adaptive fitting algorithm.
    Sofue K; Mileto A; Dale BM; Zhong X; Bashir MR
    J Magn Reson Imaging; 2015 Nov; 42(5):1281-90. PubMed ID: 25920074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between incidental fat deposition in the liver and pancreas in asymptomatic individuals.
    Aliyari Ghasabeh M; Shaghaghi M; Khoshpouri P; Pan L; Pandy A; Pandy P; Zhong X; Kannengiesser S; Kamel IR
    Abdom Radiol (NY); 2020 Jan; 45(1):203-210. PubMed ID: 31482380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
    Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
    Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3D Multi-Echo Dixon technique for simultaneous assessment of liver steatosis and iron overload in patients with chronic liver diseases: a feasibility study.
    Hu F; Yang R; Huang Z; Wang M; Yuan F; Xia C; Wei Y; Song B
    Quant Imaging Med Surg; 2019 Jun; 9(6):1014-1024. PubMed ID: 31367555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of hepatic steatosis and iron content at 3 Tesla: comparison of two-point Dixon, quantitative multi-echo Dixon, and MR spectroscopy.
    Zhan C; Olsen S; Zhang HC; Kannengiesser S; Chandarana H; Shanbhogue KP
    Abdom Radiol (NY); 2019 Sep; 44(9):3040-3048. PubMed ID: 31286208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
    Martí-Aguado D; Jiménez-Pastor A; Alberich-Bayarri Á; Rodríguez-Ortega A; Alfaro-Cervello C; Mestre-Alagarda C; Bauza M; Gallén-Peris A; Valero-Pérez E; Ballester MP; Gimeno-Torres M; Pérez-Girbés A; Benlloch S; Pérez-Rojas J; Puglia V; Ferrández A; Aguilera V; Escudero-García D; Serra MA; Martí-Bonmatí L
    Radiology; 2022 Feb; 302(2):345-354. PubMed ID: 34783592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Automated vessel exclusion technique for quantitative assessment of hepatic iron overload by R2*-MRI.
    Tipirneni-Sajja A; Song R; McCarville MB; Loeffler RB; Hankins JS; Hillenbrand CM
    J Magn Reson Imaging; 2018 Jun; 47(6):1542-1551. PubMed ID: 29083524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease.
    Idilman IS; Keskin O; Elhan AH; Idilman R; Karcaaltincaba M
    Scand J Gastroenterol; 2014 May; 49(5):617-24. PubMed ID: 24694249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic iron and fat assessment by MRI-R2* in patients with iron overload diseases.
    Pfeifer CD; Schoennagel BP; Grosse R; Wang ZJ; Graessner J; Nielsen P; Adam G; Fischer R; Yamamura J
    J Magn Reson Imaging; 2015 Jul; 42(1):196-203. PubMed ID: 25236606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver R2* is affected by both iron and fat: A dual biopsy-validated study of chronic liver disease.
    Karlsson M; Ekstedt M; Dahlström N; Forsgren MF; Ignatova S; Norén B; Dahlqvist Leinhard O; Kechagias S; Lundberg P
    J Magn Reson Imaging; 2019 Jul; 50(1):325-333. PubMed ID: 30637926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adding liver R2* quantification to proton density fat fraction MRI of vertebral bone marrow improves the prediction of osteoporosis.
    Lu F; Zhao YJ; Ni JM; Jiang Y; Chen FM; Wang ZJ; Zhang ZY
    Eur Radiol; 2022 Oct; 32(10):7108-7116. PubMed ID: 35610386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standardized Approach for ROI-Based Measurements of Proton Density Fat Fraction and R2* in the Liver.
    Campo CA; Hernando D; Schubert T; Bookwalter CA; Pay AJV; Reeder SB
    AJR Am J Roentgenol; 2017 Sep; 209(3):592-603. PubMed ID: 28705058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of Liver Fat Content With Unenhanced MDCT: Phantom and Clinical Correlation With MRI Proton Density Fat Fraction.
    Pickhardt PJ; Graffy PM; Reeder SB; Hernando D; Li K
    AJR Am J Roentgenol; 2018 Sep; 211(3):W151-W157. PubMed ID: 30016142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.